Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and Aug 2026.
- Largest single sale: $640K (800 shares) of Regeneron Pharmaceuticals on Aug 10, 2026. Filing
- Last sale before this period: Jan 2, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | Director | Sep 12, 2016 | Aug 12, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 10, 2026, Regeneron Pharmaceuticals: sold 800 shares for $640K, under a disclosed plan; 800 shares acquired by exercising options. 1 filing: 1
- Feb 19, 2026, Regeneron Pharmaceuticals: sold 1,638 shares for $1.3M, under a disclosed plan; 1,638 shares acquired by exercising options. 1 filing: 1
- Jan 2, 2026, Regeneron Pharmaceuticals: 155 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.